Standards for sickle cell and thalassaemia screening

This document sets out the quality standards for the sickle cell and thalassaemia (SCT) antenatal and newborn screening programme


Sickle cell and thalassaemia screening: programme standards

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This publication explains the programme standards for monitoring the SCT antenatal and newborn screening programme.

The generic newborn blood spot screening standards also apply.

Published 1 November 2011
Last updated 8 February 2018 + show all updates
  1. Addition of links to inheritance risk table from Standard 5 definitions
  2. Publication of revised programme standards that will apply from 1 April 2017 and archiving of previous version.
  3. First published.